Who
John Spencer
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Oragenics.
In numbers
- Trades disclosed
- 2
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Jul 2026
- Last trade
- 1 Jul 2026
- Last filed
- 7 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jul 2026filed 7 Jul 2026 | OGEN Oragenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —55,900 at $0.00 | filing |
| 1 Jul 2026filed 7 Jul 2026 | OGEN Oragenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —55,900 at $0.00 | filing |
News
Dr. John Spencer Ellis Reveals How Press Releases Help Med Spasopenpr.com · 28 Sep 2026
1 headline in the last 90 days name John Spencer; no company of theirs resolves to a name we track.
Sectors
No trade we could place in a sector.